WHO Classification of Tumours Editorial Board (2021) WHO Classification of Tumours, 5th edition, Volume 6: Central Nervous System Tumours. IARC, City

Bernstein KD, Sethi R, Trofimov A, Zeng C, Fullerton B, Yeap BY, Ebb D, Tarbell NJ, Yock TI, MacDonald SM (2013) Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. Int J Radiat Oncol 86:114–120. https://doi.org/10.1016/j.ijrobp.2012.12.004

Article  Google Scholar 

Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Can Res 59:74–79

CAS  Google Scholar 

Bonaglia MC, Giorda R, Beri S, De Agostini C, Novara F, Fichera M, Grillo L, Galesi O, Vetro A, Ciccone R et al (2011) Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome. PLoS Genet 7:e1002173. https://doi.org/10.1371/journal.pgen.1002173

CAS  Article  PubMed  PubMed Central  Google Scholar 

Byers HM, Adam MP, LaCroix A, Leary SE, Cole B, Dobyns WB, Mefford HC (2017) Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22. Am J Med Genet A 173:245–249. https://doi.org/10.1002/ajmg.a.37993

CAS  Article  PubMed  Google Scholar 

Cho EH, Park JB, Kim JK (2014) Atypical teratoid rhabdoid brain tumor in an infant with ring chromosome 22. Korean J Pediatr 57:333–336. https://doi.org/10.3345/kjp.2014.57.7.333

Article  PubMed  PubMed Central  Google Scholar 

Crocco M, Panciroli M, Milanaccio C, Morerio C, Verrico A, Garre ML, Di Iorgi N, Capra V (2021) Case report: the emerging role of ring chromosome 22 in Phelan-Mcdermid syndrome with atypical teratoid/rhabdoid tumor: the first child treated with growth hormone. Front Neurol 12:741062. https://doi.org/10.3389/fneur.2021.741062

Article  PubMed  PubMed Central  Google Scholar 

Johann PD, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V, Jones DTW, Sturm D, Hermann C, Segura Wang M et al (2016) Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell 29:379–393. https://doi.org/10.1016/j.ccell.2016.02.001

CAS  Article  PubMed  Google Scholar 

Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, Totoki Y, Chiba K, Sato-Otsubo A, Nagae G et al (2015) Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet 47:1304–1315. https://doi.org/10.1038/ng.3415

CAS  Article  PubMed  Google Scholar 

Nikitina TV, Kashevarova AA, Gridina MM, Lopatkina ME, Khabarova AA, Yakovleva YS, Menzorov AG, Minina YA, Pristyazhnyuk IE, Vasilyev SA et al (2021) Complex biology of constitutional ring chromosomes structure and (in)stability revealed by somatic cell reprogramming. Sci Rep 11:4325. https://doi.org/10.1038/s41598-021-83399-3

CAS  Article  PubMed  PubMed Central  Google Scholar 

Ostrom QT, Chen Y, MdB P, Ondracek A, Farah P, Gittleman H, Wolinsky Y, Kruchko C, Cohen ML, Brat DJ et al (2014) The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001–2010. Neuro Oncol 16:1392–1399. https://doi.org/10.1093/neuonc/nou090

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71

Article  PubMed  PubMed Central  Google Scholar 

Phelan K, Rogers RC, Boccuto L (1993) Phelan–McDermid syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Mirzaa GM, Amemiya A (eds) GeneReviews((R)), City

Rubio A (1997) March 1997—4 year old girl with ring chromosome 22 and brain tumor. Brain Pathol 7:1027–1028. https://doi.org/10.1111/j.1750-3639.1997.tb00902.x

CAS  Article  PubMed  Google Scholar 

Sathyamoorthi S, Morales J, Bermudez J, McBride L, Luquette M, McGoey R, Oates N, Hales S, Biegel JA, Lacassie Y (2009) Array analysis and molecular studies of INI1 in an infant with deletion 22q13 (Phelan–McDermid syndrome) and atypical teratoid/rhabdoid tumor. Am J Med Genet A 149A:1067–1069. https://doi.org/10.1002/ajmg.a.32775

Article  PubMed  PubMed Central  Google Scholar 

Takeuchi Y, Yoshida K, Halik A, Kunitz A, Suzuki H, Kakiuchi N, Shiozawa Y, Yokoyama A, Inoue Y, Hirano T et al (2022) The landscape of genetic aberrations in myxofibrosarcoma. Int J Cancer. https://doi.org/10.1002/ijc.34051

Article  PubMed  Google Scholar 

Terada Y, Jo N, Arakawa Y, Sakakura M, Yamada Y, Ukai T, Kabata M, Mitsunaga K, Mineharu Y, Ohta S et al (2019) Human pluripotent stem cell-derived tumor model uncovers the embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor. Cell Rep 26:2608. https://doi.org/10.1016/j.celrep.2019.02.009

CAS  Article  PubMed  Google Scholar 

Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203–206. https://doi.org/10.1038/28212

CAS  Article  PubMed  Google Scholar 

Ziats CA, Jain L, McLarney B, Vandenboom E, DuPont BR, Rogers C, Sarasua S, Nevado J, Cordisco EL, Phelan K et al (2020) Neurofibromatosis type 2 in Phelan–McDermid syndrome: Institutional experience and review of the literature. Eur J Med Genet 63:104042. https://doi.org/10.1016/j.ejmg.2020.104042

Article  PubMed  Google Scholar